Gender specific quality of life in patients with oral squamous cell carcinomas

Head & Face Medicine

Table 4 EORTC QLQ-C30 T- Stage

	T1 P50 [P25-P75] n [34]	T2 P50 [P25-P75] n [10]	T3 P50 [P25-P75] n [3]	T4 P50 [P25-P75] n [7]	p[T1/T2-T3/T4]
General health	33 [12-50]	29 [12-37.5]	33 [16-50]	33 [25-33]	> 0.999
Bodily function	75 [53-81.5]	83 [58.5-86.25]	40 [13-73]	67 [27-75]	0.018
Role functioning	16.5 [0-67]	58.5 [12-100]	33 [17-100]	50 [0-67]	0.432
Emotional functioning	58 [0-77]	74 [45.75-79.25]	75 [67-92]	33 [33-67]	0.719
Cognitive functioning	25 [0-75]	71 [0-83]	67 [0-100]	83 [67-83]	0.031
Social functioning	16 [0-67]	67 [0-87.25]	50 [0-67]	50 [0-67]	0.752
Fatigue	27.5 [0-58.75]	61.5 [24.75-67]	100 [22-100]	67 [0-100]	0.098
Nausea/Vomiting	0 [0-20.25]	8 [0-37.25]	50 [33-100]	0 [0-16]	0.187
Pain	33 [0-67]	58.5 [0-71]	33 [33-83]	33 [0-83]	0.800
Dyspnea	33 [0-66]	33 [0-50]	33 [0-33]	16.5 [0-49.75]	0.846
Sleep disorders	66 [24.75-100]	50 [25.75-100]	33 [0-33]	33 [0-100]	0.218
Loss of appetite	0 [0-41.4]	33 [0-67]	100 [0-100]	0 [0-67]	0.475
Constipation	0 [0-100]	0 [0-0]	0 [0-33]	0 [0-67]	0.630
Diarrhea	0 [0-33]	0 [0-33]	0 [0-100]	0 [0-33]	0.438
Financial stress	0 [0-67]	33 [-75.25]	0 [0-67]	33 [0-100]	0.614

ISSN: 1746-160X